Brookstone Capital Management Reduces Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Brookstone Capital Management trimmed its stake in ARK Genomic Revolution ETF (BATS:ARKG) by 4.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,985 shares of the company’s stock after selling 4,483 shares during the period. Brookstone Capital Management owned approximately 0.15% of ARK Genomic Revolution ETF worth $3,315,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Truist Financial Corp lifted its holdings in shares of ARK Genomic Revolution ETF by 17.3% in the 1st quarter. Truist Financial Corp now owns 18,765 shares of the company’s stock valued at $564,000 after purchasing an additional 2,763 shares during the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its holdings in shares of ARK Genomic Revolution ETF by 1,017.9% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 45,858 shares of the company’s stock valued at $1,295,000 after acquiring an additional 41,756 shares during the period. Citigroup Inc. grew its position in shares of ARK Genomic Revolution ETF by 352.7% during the first quarter. Citigroup Inc. now owns 1,402,857 shares of the company’s stock worth $42,184,000 after acquiring an additional 1,092,968 shares during the last quarter. AlphaMark Advisors LLC increased its holdings in shares of ARK Genomic Revolution ETF by 12.4% in the 1st quarter. AlphaMark Advisors LLC now owns 4,570 shares of the company’s stock valued at $137,000 after acquiring an additional 505 shares during the period. Finally, Wealthfront Advisers LLC raised its position in ARK Genomic Revolution ETF by 8.8% in the 1st quarter. Wealthfront Advisers LLC now owns 36,418 shares of the company’s stock valued at $1,095,000 after purchasing an additional 2,951 shares during the last quarter.

ARK Genomic Revolution ETF Trading Down 2.9 %

Shares of ARK Genomic Revolution ETF stock opened at $29.62 on Tuesday. The stock’s 50-day simple moving average is $33.40 and its two-hundred day simple moving average is $32.07.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.